Jagsonpal Pharmaceuticals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -2.04% vs -1.51% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -12.89% vs 16.39% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.97% vs 15.69% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -3.70% vs 8.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Jagsonpal Pharma With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

72.95

121.44

-48.49

-39.93%

Other Operating Income

0.00

Total Operating income

72.95

121.44

-48.49

-39.93%

Raw Material Cost

3.95

46.43

-42.48

-91.49%

Purchase of Finished goods

22.81

15.35

7.46

48.60%

(Increase) / Decrease In Stocks

-0.31

9.09

-9.40

-103.41%

Employee Cost

17.58

16.73

0.85

5.08%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

12.64

15.11

-2.47

-16.35%

Total Expenditure (Excl Depreciation)

56.67

102.71

-46.04

-44.83%

Operating Profit (PBDIT) excl Other Income

16.28

18.73

-2.45

-13.08%

Other Income

2.98

5.23

-2.25

-43.02%

Operating Profit (PBDIT)

19.26

23.96

-4.70

-19.62%

Interest

0.26

0.25

0.01

4.00%

Exceptional Items

-2.08

0.00

-2.08

Gross Profit (PBDT)

16.92

23.71

-6.79

-28.64%

Depreciation

2.39

1.35

1.04

77.04%

Profit Before Tax

14.52

22.36

-7.84

-35.06%

Tax

3.57

5.52

-1.95

-35.33%

Provisions and contingencies

0.00

Profit After Tax

10.95

16.84

-5.89

-34.98%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

10.95

16.84

-5.89

-34.98%

Equity Capital

13.36

94.00

-80.64

-85.79%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.64

0.18

1.46

811.11%

Diluted Earnings per share

1.65

0.18

1.47

816.67%

Operating Profit Margin (Excl OI)

22.32%

15.42%

0.00

6.90%

Gross Profit Margin

23.19%

19.52%

0.00

3.67%

PAT Margin

15.01%

13.87%

0.00

1.14%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 72.95 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -2.04% vs -1.51% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -1.46% vs 56.74% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 10.95 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -12.89% vs 16.39% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -65.77% vs 707.83% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 16.28 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.97% vs 15.69% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 2.78% vs 367.26% in Dec 2024

Quarterly - Interest

Interest 0.26 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -3.70% vs 8.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 0.00% vs 13.04% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 22.32%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024